Davis Polk & Wardwell is advising Genetron Holdings Limited and, separately, the special committee of the board of directors of Genetron on the transaction, Skadden, Arps,...
You must be a Standard 1 Year member to access this content.
Davis Polk advised Sirio Pharma Co. Ltd. on the deal. Sirio Pharma announced the acquisition of a majority stake of Best Formulations, as part of its strategy to...
You must be a Standard 1 Year member to access this content.
Davis Polk advised InSilico Medicine in the transaction. InSilico Medicine completed its $35 million Series D2 financing, bringing the total Series D financing to $95 million....
You must be a Standard 1 Year member to access this content.
Davis Polk advised InSilico Medicine in the transaction. InSilico Medicine, a clinical-stage end-to-end artificial intelligence (AI)-driven drug discovery company, closed its $60 million Series D financing...
You must be a Standard 1 Year member to access this content.
Davis Polk advised Laekna Therapeutics in the transaction. Laekna Therapeutics completed its $61 million Series D financing led by CS Capital with support from Worldstar, and Infinity...
You must be a Standard 1 Year member to access this content.
Davis Polk advised Inner Mongolia Yili Industrial Group on the deal. Inner Mongolia Yili Industrial Group Co., Ltd executed the acquisition of 34.33% of Ausnutria Dairy...
You must be a Standard 1 Year member to access this content.
Davis Polk, working alongside Conyers, advised Kingsoft Cloud Holdings Limited in the transaction. Kingsoft Cloud Holdings Limited announced its acquisition of controlling interests in Camelot Employee...
You must be a Standard 1 Year member to access this content.
